Vascular Graft Market size to surpass $6.5Bn by 2032

Vascular Graft Market size is anticipated to cross USD 6.5 billion by 2032, as per a new research report announced by Global Market Insights Inc.
 

Increase in chronic diseases to act as the chief driver for the vascular graft industry trends. The rise in the number of cardiovascular disorders has increased the demand for coronary artery bypass grafting (CABG) surgeries, which provide a long-term revascularization treatment. According to the CDC, six out of ten persons in the U.S. suffer from at least one chronic illness, such as diabetes, cancer, heart disease, or stroke. Additionally, mounting government spending toward the healthcare sector is propelling the frequency of CABG operations.
 

Growing need for hemodialysis to increase the use of polyurethane vascular graft

Vascular graft market share from polyurethane grafts segment to depict more than 4.5% CAGR by 2032. Polyurethane grafts offer early cannulation with infections as compared to polytetrafluoroethylene grafts. Hemodialysis is becoming necessary on account of the rise in incidences of end-stage renal diseases. Thus, the escalating usage of polyurethane vascular grafts for early and quick cannulation in patients receiving hemodialysis is likely to foster segment outlook.
 

Browse key industry insights spread across 154 pages with 205 market data tables & 13 figures & charts from the report, “Vascular Graft Market Size By Raw Material (Polyester Grafts, EPTFE Grafts, Polyurethane Grafts, Biosynthetic Grafts), Application (Endovascular Aneurysm Repair {Abdominal Aortic Aneurysm Repair, Thoracic Aortic Aneurysm Repair}, Peripheral Vascular Repair, Hemodialysis Access), End-use (Hospitals, Ambulatory Surgical Centers), COVID-19 Impact Analysis, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 – 2032” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/vascular-graft-market
 

Surge in smoking to push peripheral vascular repair demand

Peripheral artery disease, which is caused by diabetes, high blood pressure, high cholesterol, kidney failure, obesity, and smoking, necessitates the uptake of peripheral vascular repair techniques, which is speculated to impel peripheral vascular repair progression. A study published by the Journal of the American Heart Association examined over 1200 PAD patients and found that 90% of them were former smokers. Thus, the escalating prevalence of smoking to bolster product adoption for these procedures.
 

Availability of affordable treatments to augment vascular grafting in ASCs

The deployment of vascular grafts for patient care in ambulatory surgical centers is speculated to remain high in the coming years. Soaring patient preference for ambulatory centers due to several advantages offered by these facilities, including high-quality care, a low risk of hospital-acquired infections (HAIs), shorter hospital stays, and affordable treatment, is set to propel segment growth.
 

Mounting number of renal diseases to help Europe vascular graft industry expansion

Europe vascular graft market is slated to hit over USD 1.8 billion by 2032. The region may emerge as a major hub for this industry owing to the high prevalence of chronic kidney diseases. The end-stage renal illness affects a significant section of the population in Europe, which is increasing the need for hemodialysis access across the region. Around 75 million individuals in the region suffer from chronic kidney disease, which is estimated to become the 5^th cause of death worldwide by 2040. This is projected to bolster the utilization of vascular grafts.
 

Promising acquisitions and partnerships to remain a key development strategy

Some of the key players profiled in the vascular graft market report include Cook Medical, Medtronic, Merit Medical, Terumo Corporation, Getinge AB, LeMaitre Vascular, Vascular Graft Solution, and W. L. Gore & Associates, Inc., and others.